| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schwartz Aharon is a Director at PLX. Recent filings cover 3 purchases and 0 sales. Those positions are worth an estimated $18K at current prices.
Schwartz Aharon's largest disclosed position is in PLX as Director, worth about $18K. Net of sales, the recent Form 4 record there shows accumulation of 303,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 129,000 | $1.60 | $205,884.00 | +74.1% | 0.0% | +25.9% | |
| Jan 3, 2023 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 110,000 | $1.42 | $155,815.00 | +171.9% | +61.3% | +30.7% | |
| Apr 7, 2020 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 64,000 | $2.43 | $155,264.00 | New | - | - |